CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(In millions, except number of shares which are reflected in thousands)
Common Stock and Accumulated
Additional Paid-In Capital Other _ Total
: : Retained Comprehenswe Shareholders’
Shares Amount Earnings Income/(Loss) Equity
Balances as of September 28, 2013 6,294,494 $ 19,764 $ 104,256 $ (471) $ 123,549
' Net income — — 39,510 — 39,510
Other comprehensive income/(loss) — — — 1,553 1,553
Dividends and dividend equivalents
declared — — (11,215) — (11,215)
Repurchase of common stock (488,677) — (45,000) — (45,000)
I Share-based compensation — 2,863 — — 2,863 I
I Common stock issued, net of shares
withheld for employee taxes 60,344 (49) (399) — (448)
I Tax benefit from equity awards, including I
transfer pricing adjustments — 735 — — 735
Balances as of September 27, 2014 0 5,866,161 ’ ’ 23,313 ’ 87,1527 ’ 1,082’ ’ 111,547
' Net income ’ —’ ’ —’ ’ 53,394’ ’ —’ ’ 53,394’
Other comprehensive income/(loss) — — — (1,427) (1,427)
I Dividends and dividend equivalents I
declared — — (1 1 ,627) — (1 1,627)
I Repurchase of common stock (325,032) — (36,026) — (36,026)
I Share-based compensation — 3,586 — — 3,586
Common stock issued, net of shares
withheld for employee taxes 37,624 (231) (609) — (840)
I Tax benefit from equity awards, including I
transfer pricing adjustments — 748 — — 748
Balances as of September 26, 2015 ’ 5,578,753 ’ 27,416’ ’ 92,284’ ’ (345) ’ 119,355
' Net income ’ —’ ’ —’ ’ 45,6877 ’ —’ ’ 45,687
I Other comprehensive income/(loss) — — — 979 979
I Dividends and dividend equivalents I
declared — — (12,188) — (12,188)
Repurchase of common stock (279,609) — (29,000) — (29,000)
Share-based compensation — 4,262 — — 4,262
Common stock issued, net of shares
withheld for employee taxes 37,022 (806) (419) — (1,225)
I Tax benefit from equity awards, including I
transfer pricing adjustments — 379 — — 379
Balances as of September 24, 2016 ’ 5,336,166 ’$ 31,251 ’ ’$ 96,364 ’$ 634’ ’3 128,249,
See accompanying Notes to Consolidated Financial Statements.
Apple Inc. | 2016 Form 10-K l 42